Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

McMaster University

$194,048.00

Developing a fully integrated universal platform for POC diagnostics: Integrating digital microfluidics with electrochemical biosensing

FY 2023-24

Summary
There is an unmet need for remote care technologies that, in addition to telemedicine features, have the capability to generate laboratory results on location. The collaboration between the academic team at McMaster University and the industry team at Verv Technologies is focused on integrating electrochemical sensing technology (McMaster) with microfluidics and automation prototypes (Verv) for creating a fully-integrated remote bioanalytical system. The proposal will aim at 1) creating new electrode materials for improving the performance and versatility of the existing Verv prototype, 2) developing a cardiac panel test used for monitoring cardiac patients, and 3) employing machine learning algorithms to improve the accuracy of clinical decision making offered by the system.Verv Technologies has put in place the technical, business development, quality management, and regulatory teams to commercialize the outcomes of this proposal. As a result, this project will generate several jobs directly at Verv and at its Canadian manufacturing partners and will lead to an expert stream, generating positive economic outcomes for Canada. In addition, the project will train highly qualified personnel, ranging from undergraduate students to postdoctoral fellows, contributing to Canada's training-research-translation continuum. This will have the benefit of supporting the local biotechnology industry with the much-needed talent for success, which will in turn result in the employment of more of such talent in Canada, contributing to the circular biotechnology ecosystem. Additionally, the technology developed herein will improve the quality and equity of healthcare across Canada and around the world, especially for those in remote and under-resourced communities, helping to sustain Canada's reputation in healthcare excellence.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
590436-2023
Name nom
Soleymani, Leyla L
Department département
Engineering Physics
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
194048
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Bioanalytical chemistry
Research subject en
Chimie analytique
Research subject fr
Chimie bioanalytique
Application title
Developing a fully integrated universal platform for POC diagnostics: Integrating digital microfluidics with electrochemical biosensing
Keyword
Bio-assays; Bio-barcoding; Biosensors; Cardiovascular panels; DNA; Electrochemistry; Functional nucleic acids; Microfluidics; Multiplexing; Proteins
Application summary
There is an unmet need for remote care technologies that, in addition to telemedicine features, have the capability to generate laboratory results on location. The collaboration between the academic team at McMaster University and the industry team at Verv Technologies is focused on integrating electrochemical sensing technology (McMaster) with microfluidics and automation prototypes (Verv) for creating a fully-integrated remote bioanalytical system. The proposal will aim at 1) creating new electrode materials for improving the performance and versatility of the existing Verv prototype, 2) developing a cardiac panel test used for monitoring cardiac patients, and 3) employing machine learning algorithms to improve the accuracy of clinical decision making offered by the system.Verv Technologies has put in place the technical, business development, quality management, and regulatory teams to commercialize the outcomes of this proposal. As a result, this project will generate several jobs directly at Verv and at its Canadian manufacturing partners and will lead to an expert stream, generating positive economic outcomes for Canada. In addition, the project will train highly qualified personnel, ranging from undergraduate students to postdoctoral fellows, contributing to Canada's training-research-translation continuum. This will have the benefit of supporting the local biotechnology industry with the much-needed talent for success, which will in turn result in the employment of more of such talent in Canada, contributing to the circular biotechnology ecosystem. Additionally, the technology developed herein will improve the quality and equity of healthcare across Canada and around the world, especially for those in remote and under-resourced communities, helping to sustain Canada's reputation in healthcare excellence.
McMaster University - $194,048 Grant (2023-24) | Canada Spends